NCT07365995 2026-01-26A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate CancerBioNTech SEPhase 3 Not yet recruiting736 enrolled
NCT06480110 2025-04-13Ebastine in Combination With Docetaxel as a Treatment for Castration-resistant Metastatic Prostate CancerRigshospitalet, DenmarkPhase 1/2 Recruiting30 enrolled